144 related articles for article (PubMed ID: 27156192)
1. Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP).
Korwar S; Morris BL; Parikh HI; Coover RA; Doughty TW; Love IM; Hilbert BJ; Royer WE; Kellogg GE; Grossman SR; Ellis KC
Bioorg Med Chem; 2016 Jun; 24(12):2707-15. PubMed ID: 27156192
[TBL] [Abstract][Full Text] [Related]
2. Structure-guided design of a high affinity inhibitor to human CtBP.
Hilbert BJ; Morris BL; Ellis KC; Paulsen JL; Schiffer CA; Grossman SR; Royer WE
ACS Chem Biol; 2015 Apr; 10(4):1118-27. PubMed ID: 25636004
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of C-terminal binding protein in human cancer.
Straza MW; Paliwal S; Kovi RC; Rajeshkumar B; Trenh P; Parker D; Whalen GF; Lyle S; Schiffer CA; Grossman SR
Cell Cycle; 2010 Sep; 9(18):3740-50. PubMed ID: 20930544
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design.
Hilbert BJ; Grossman SR; Schiffer CA; Royer WE
FEBS Lett; 2014 May; 588(9):1743-8. PubMed ID: 24657618
[TBL] [Abstract][Full Text] [Related]
5. Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities.
Dcona MM; Damle PK; Zarate-Perez F; Morris BL; Nawaz Z; Dennis MJ; Deng X; Korwar S; Singh SJ; Ellis KC; Royer WE; Bandyopadhyay D; Escalante C; Grossman SR
Mol Pharmacol; 2019 Jul; 96(1):99-108. PubMed ID: 31036695
[TBL] [Abstract][Full Text] [Related]
6. CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors.
Dcona MM; Morris BL; Ellis KC; Grossman SR
Cancer Biol Ther; 2017 Jun; 18(6):379-391. PubMed ID: 28532298
[TBL] [Abstract][Full Text] [Related]
7. CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4.
Wang L; Zhou H; Wang Y; Cui G; Di LJ
Cell Death Dis; 2015 Jan; 6(1):e1620. PubMed ID: 25633289
[TBL] [Abstract][Full Text] [Related]
8. CPP-E1A fusion peptides inhibit CtBP-mediated transcriptional repression.
Blevins MA; Zhang C; Zhang L; Li H; Li X; Norris DA; Huang M; Zhao R
Mol Oncol; 2018 Aug; 12(8):1358-1373. PubMed ID: 29879296
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
Filograna A; De Tito S; Monte ML; Oliva R; Bruzzese F; Roca MS; Zannetti A; Greco A; Spano D; Ayala I; Liberti A; Petraccone L; Dathan N; Catara G; Schembri L; Colanzi A; Budillon A; Beccari AR; Del Vecchio P; Luini A; Corda D; Valente C
J Exp Clin Cancer Res; 2024 May; 43(1):137. PubMed ID: 38711119
[TBL] [Abstract][Full Text] [Related]
10. Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression.
Blevins MA; Kouznetsova J; Krueger AB; King R; Griner LM; Hu X; Southall N; Marugan JJ; Zhang Q; Ferrer M; Zhao R
J Biomol Screen; 2015 Jun; 20(5):663-72. PubMed ID: 25477201
[TBL] [Abstract][Full Text] [Related]
11. Assembly of human C-terminal binding protein (CtBP) into tetramers.
Bellesis AG; Jecrois AM; Hayes JA; Schiffer CA; Royer WE
J Biol Chem; 2018 Jun; 293(23):9101-9112. PubMed ID: 29700119
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and SAR analysis of cytotoxic sinapyl alcohol derivatives.
Zou HB; Dong SY; Zhou CX; Hu LH; Wu YH; Li HB; Gong JX; Sun LL; Wu XM; Bai H; Fan BT; Hao XJ; Stöckigt J; Zhao Y
Bioorg Med Chem; 2006 Mar; 14(6):2060-71. PubMed ID: 16303311
[TBL] [Abstract][Full Text] [Related]
13. Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization.
Banerjee A; Birts CN; Darley M; Parker R; Mirnezami AH; West J; Cutress RI; Beers SA; Rose-Zerilli MJJ; Blaydes JP
Carcinogenesis; 2019 Jul; 40(7):871-882. PubMed ID: 30668646
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation by C-terminal binding proteins.
Chinnadurai G
Int J Biochem Cell Biol; 2007; 39(9):1593-607. PubMed ID: 17336131
[TBL] [Abstract][Full Text] [Related]
15. MCRIP1, an ERK substrate, mediates ERK-induced gene silencing during epithelial-mesenchymal transition by regulating the co-repressor CtBP.
Ichikawa K; Kubota Y; Nakamura T; Weng JS; Tomida T; Saito H; Takekawa M
Mol Cell; 2015 Apr; 58(1):35-46. PubMed ID: 25728771
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Activities of Novel Pyrazole Oxime Compounds Containing a Substituted Pyridyl Moiety.
Chen C; Chen J; Gu H; Bao N; Dai H
Molecules; 2017 May; 22(6):. PubMed ID: 28587083
[TBL] [Abstract][Full Text] [Related]
17. 2-Keto-4-methylthiobutyrate, an intermediate in the methionine salvage pathway, is a good substrate for CtBP1.
Achouri Y; Noël G; Van Schaftingen E
Biochem Biophys Res Commun; 2007 Jan; 352(4):903-6. PubMed ID: 17157814
[TBL] [Abstract][Full Text] [Related]
18. Functional knockout of the corepressor CtBP by the second exon of adenovirus E1a relieves repression of transcription.
Sundqvist A; Bajak E; Kurup SD; Sollerbrant K; Svensson C
Exp Cell Res; 2001 Aug; 268(2):284-93. PubMed ID: 11478854
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines.
Zhang Q; Dong J; Cui J; Huang G; Meng Q; Li S
Chem Pharm Bull (Tokyo); 2018; 66(6):612-619. PubMed ID: 29863062
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinases.
Xu G; Searle LL; Hughes TV; Beck AK; Connolly PJ; Abad MC; Neeper MP; Struble GT; Springer BA; Emanuel SL; Gruninger RH; Pandey N; Adams M; Moreno-Mazza S; Fuentes-Pesquera AR; Middleton SA; Greenberger LM
Bioorg Med Chem Lett; 2008 Jun; 18(12):3495-9. PubMed ID: 18508264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
